A phase II study of a THP-COP regimen for the treatment of elderly patients aged 70 years or older with diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

A phase II study of a THP-COP regimen for the treatment of elderly patients aged 70 years or older with diffuse large B-cell lymphoma

Published:2007 Issue:3 Volume:25 Page:107-114
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol. Oncol.

Author:

Tsurumi Hisashi,Hara Takeshi,Goto Naoe,Kanemura Nobuhiro,Kasahara Senji,Sawada Michio,Yasuda Ichiro,Yamada Toshiki,Shimizu Masahito,Takami Tsuyoshi,Moriwaki Hisataka

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference34 articles.

1. Non-Hodgkin's lymphoma in the elderly I. Pathologic features at presentation

2. The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma.

3. Tetrahydropyranyl derivatives of daunomycin and adriamycin.

4. Prospects for pirarubicin

5. (2?-R)-4?-o-Tetrahydropyranyladriamycin, a new anthracycline derivative; its effectiveness in lymphoid malignancies

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complete detection of FR1 to FR3 primer‐based PCR patterns of immunoglobulin heavy chain rearrangement in the BIOMED‐2 protocol is associated with poor prognosis in patients with diffuse large B‐cell lymphoma;eJHaem;2024-06-18

2. Berberine increases the killing effect of pirarubicin on HCC cells by inhibiting ATG4B-autophagy pathway;Experimental Cell Research;2024-06

3. An evaluation based on relative treatment intensity in older patients treated with reduced-dose R-THP-COP therapy for diffuse large B-cell lymphoma: A multicenter retrospective cohort study;Journal of Geriatric Oncology;2023-01

4. A multicenter, phase II study of full-dose THP-COP therapy for elderly patients with newly diagnosed, advanced-stage, aggressive non-Hodgkin lymphoma;Journal of Clinical and Experimental Hematopathology;2022

5. Viability of diffuse large B-cell lymphoma cells is regulated by kynurenine 3-monooxygenase activity;Oncology Letters;2021-09-17